Business Description
Neola Medical AB
ISIN : SE0014829255
Share Class Description:
OSTO:NEOLA: Ordinary SharesTotal Employee Number:
9Compare
Compare
Traded in other countries / regions
NEOLA.Sweden IPO Date
2020-10-02Description
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provideĀ care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions toĀ health care.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 29.9 | |||||
3-Year EPS without NRI Growth Rate | 29.5 | |||||
3-Year FCF Growth Rate | 28.8 | |||||
3-Year Book Growth Rate | -7.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 12.7 | |||||
9-Day RSI | 19.94 | |||||
14-Day RSI | 26.31 | |||||
3-1 Month Momentum % | -29.45 | |||||
6-1 Month Momentum % | -7.97 | |||||
12-1 Month Momentum % | -58.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.75 | |||||
Quick Ratio | 5.75 | |||||
Cash Ratio | 5.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.9 | |||||
Shareholder Yield % | -27.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -14.18 | |||||
ROA % | -13.47 | |||||
ROIC % | -18.27 | |||||
3-Year ROIIC % | -2.75 | |||||
ROC (Joel Greenblatt) % | -5140.41 | |||||
ROCE % | -14.27 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.68 | |||||
Price-to-Tangible-Book | 3.53 | |||||
EV-to-EBIT | -4.87 | |||||
EV-to-EBITDA | -5.57 | |||||
EV-to-FCF | -4.66 | |||||
| Price-to-Net-Current-Asset-Value | 3.53 | |||||
| Price-to-Net-Cash | 3.97 | |||||
Earnings Yield (Greenblatt) % | -20.53 | |||||
FCF Yield % | -16.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Neola Medical AB Executives
DetailsGF Valueā¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.146 | ||
| Beta | 1.4118 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 83.59 | ||
| 14-Day RSI | 26.31 | ||
| 14-Day ATR (kr) | 0.054855 | ||
| 20-Day SMA (kr) | 0.81575 | ||
| 12-1 Month Momentum % | -58.77 | ||
| 52-Week Range (kr) | 0.581477 - 2.414772 | ||
| Shares Outstanding (Mil) | 110.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neola Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neola Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 105 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 105 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 | In 28 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 28 days | ||
| General meeting for 2026 | 2026-05-28 15:00 | 1.05 (-1.80%) | ||
| First quarter earnings conference call for 2026 | 2026-05-19 | 1.04 (-1.82%) | ||
| First quarter earnings results for 2026 | 2026-05-19 | 1.04 (-1.82%) | ||
| Annual report for 2025 | 2026-04-21 | 0.73 (+4.83%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 11:00 | 0.71 (-3.93%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | 0.71 (-3.93%) |
Show
Entries
Neola Medical AB Frequently Asked Questions
What is Neola Medical AB(OSTO:NEOLA)'s stock price today?
The current price of OSTO:NEOLA is kr0.64. The 52 week high of OSTO:NEOLA is kr2.41 and 52 week low is kr0.58.
When is next earnings date of Neola Medical AB(OSTO:NEOLA)?
The next earnings date of Neola Medical AB(OSTO:NEOLA) is 2026-08-20.
Does Neola Medical AB(OSTO:NEOLA) pay dividends? If so, how much?
Neola Medical AB(OSTO:NEOLA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neola Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers